A phenytoin blood test measures the amount of phenytoin in the blood to help keep seizure treatment in a safe and useful range. Phenytoin is an antiseizure medicine with a narrow therapeutic window, which means the level can move from too low to too high with relatively small dose changes, missed doses, formulation switches, illness, or drug interactions. The test is most often used when seizures return, side effects suggest toxicity, a dose has recently changed, or a person has a condition that changes how much active drug is available in the body. Many reports show a total phenytoin level, but some people need a free phenytoin level because low albumin, kidney disease, pregnancy, older age, or critical illness can make the total number misleading. Results should be interpreted with the dose, timing of the last dose, symptoms, albumin level, other medicines, and seizure control.
- A common total phenytoin therapeutic range is 10–20 mcg/mL, which is the same as 10–20 mg/L.
- A common free phenytoin therapeutic range is about 1–2 mcg/mL, but labs may use slightly different reference ranges.
- Levels above 20 mcg/mL increase the chance of toxicity, especially nystagmus, double vision, poor coordination, slurred speech, confusion, or severe drowsiness.
- A low level can mean missed doses, poor absorption, interacting medicines, a dose that is too low, or blood drawn before steady levels were reached.
- The most useful sample is often a trough level, drawn just before the next dose, unless the clinician requests a different timing.
- Seek urgent medical help for severe confusion, inability to walk safely, fainting, serious rash, trouble breathing, abnormal heart rhythm symptoms, coma, or seizures.
Table of Contents
- What the phenytoin blood test measures
- Therapeutic range, toxic level, and result patterns
- When phenytoin levels are checked
- How to prepare and when the sample is drawn
- Total vs free phenytoin results
- Causes of high or low phenytoin levels
- Toxicity symptoms and urgent follow-up
- How results guide dose changes
What the phenytoin blood test measures
A phenytoin blood test measures the concentration of phenytoin circulating in the blood. Phenytoin is used to help prevent certain seizures, including focal seizures and generalized tonic-clonic seizures. It may also be used in hospital settings after seizures or neurosurgery, depending on the situation.
The test is part of therapeutic drug monitoring, which means measuring a medication level to guide safer and more effective dosing. Phenytoin is a classic drug for this type of monitoring because its dose-response pattern is not simple. Once the liver enzymes that clear phenytoin become saturated, a small dose increase can cause a much larger rise in blood level than expected. A person may tolerate one dose well, then develop toxicity after what seems like a modest adjustment.
Most phenytoin blood tests report total phenytoin. Total phenytoin includes both protein-bound drug and unbound drug. The unbound portion, often called free phenytoin, is the active form that can enter tissues and affect the brain. In many stable adults with normal albumin, the total level gives enough information. In people with altered protein binding, the free level may explain symptoms better than the total level.
Phenytoin monitoring is different from many routine blood tests because the number is only one part of interpretation. A level of 8 mcg/mL may be acceptable for someone who has excellent seizure control and no symptoms. A level of 18 mcg/mL may be too high for a person with low albumin and signs of toxicity. The result must be matched to the person’s seizure history, side effects, other medicines, liver function, kidney function, nutrition, pregnancy status, and timing of the sample.
Phenytoin is often discussed with other antiseizure medication levels because several seizure medicines have measurable therapeutic ranges. For a broader comparison, see carbamazepine, phenytoin, and valproic acid level monitoring. The same general principle applies across these tests: the lab value helps, but clinical response and safety symptoms still guide decisions.
Therapeutic range, toxic level, and result patterns
The commonly used total phenytoin therapeutic range is 10–20 mcg/mL, also written as 10–20 mg/L. The commonly used free phenytoin therapeutic range is about 1–2 mcg/mL. Laboratories may report slightly different intervals, and hospitals may use different targets for certain settings.
A result below the range does not automatically mean treatment failure. Some people remain seizure-free at lower levels. A result inside the range does not guarantee safety or seizure control. A result above the range increases the chance of toxicity, but symptoms and free drug exposure matter more than the total number alone.
| Result pattern | Common meaning | Typical follow-up |
|---|---|---|
| Total level below 10 mcg/mL | May be subtherapeutic, especially if seizures continue | Review dose timing, missed doses, absorption, interactions, and whether steady state was reached |
| Total level 10–20 mcg/mL | Often considered therapeutic | Interpret with seizure control, side effects, albumin, and other medicines |
| Total level above 20 mcg/mL | Higher risk of toxicity | Assess symptoms, timing, albumin, free level need, and recent dose or interaction changes |
| Normal total level with toxicity symptoms | Possible increased free phenytoin | Consider free phenytoin, albumin, kidney function, liver disease, pregnancy, or critical illness |
| High total level without symptoms | May still become toxic, especially if rising | Clinician may repeat the level, adjust dose, or check free phenytoin depending on context |
Phenytoin toxicity often becomes more likely as the total level rises above 20 mcg/mL. Symptoms often appear in a rough concentration pattern, although individual response varies:
- 20–30 mcg/mL: nystagmus, which is involuntary eye movement, may appear.
- 30–40 mcg/mL: poor coordination, unsteady walking, slurred speech, tremor, nausea, or vomiting may occur.
- 40–50 mcg/mL: marked drowsiness, confusion, or unusual behavior may develop.
- Above 50 mcg/mL: coma and seizures can occur, although very high levels or other co-ingested substances should also be considered.
These ranges are not rigid cutoffs. Older adults, people with low albumin, people with kidney failure, people with liver disease, and critically ill patients may have toxicity at lower total levels because a larger share of the drug may be free. In contrast, some people may have a mildly high total level without obvious symptoms, especially if the free level is not elevated.
Because phenytoin is strongly affected by liver metabolism and protein binding, related blood tests often help explain a confusing result. Clinicians may check albumin, a liver panel, electrolytes, kidney markers, and a complete blood count. A liver function test panel can help identify liver injury or impaired metabolism that may raise phenytoin exposure.
When phenytoin levels are checked
Phenytoin levels are not always checked on a fixed schedule in every stable person. Many clinicians use levels when the result is likely to change care. The test is especially useful when symptoms, seizure control, or a new medical situation raises concern that the dose is no longer right.
A phenytoin level may be ordered when:
- Seizures return after a period of control.
- A person has possible toxicity symptoms, such as nystagmus, double vision, slurred speech, poor coordination, confusion, or severe drowsiness.
- The dose has recently changed.
- A loading dose was given in the hospital.
- A new medicine was started, stopped, or changed.
- The person switched between phenytoin products or formulations.
- There is concern about missed doses or inconsistent use.
- Pregnancy, kidney failure, liver disease, low albumin, malnutrition, critical illness, or older age may affect interpretation.
- A feeding tube, enteral nutrition, vomiting, or absorption problem may lower the level.
- A clinician is checking whether the current level matches seizure control and side effects.
The test is also useful when phenytoin is part of a larger medication safety review. Phenytoin can interact with many medicines because it is metabolized by liver enzymes and can also induce enzymes that change levels of other drugs. This can affect anticoagulants, some antibiotics, antifungals, heart medicines, hormonal contraceptives, antidepressants, other seizure medicines, and some over-the-counter or herbal products.
Therapeutic drug monitoring is not the same as a routine wellness screen. It answers a more specific question: does the measured drug exposure fit the person’s clinical situation? A broader explanation of how peak, trough, therapeutic, and toxic levels are used is available in therapeutic drug monitoring panel interpretation.
Phenytoin testing may be paired with other tests when toxicity or treatment complications are possible. A clinician may order a complete blood count if there are signs of infection, bruising, mouth ulcers, or blood cell problems. Kidney and electrolyte testing may be ordered when dehydration, kidney impairment, or acid-base problems could affect overall safety.
How to prepare and when the sample is drawn
Most phenytoin blood tests require a standard blood draw from a vein. The preparation usually depends on why the test is being done and whether the clinician wants a trough level, a post-load level, or an urgent toxicity level.
For long-term outpatient monitoring, the sample is often drawn as a trough, meaning just before the next scheduled dose. A trough is useful because it gives a more consistent low-point measurement for comparison over time. If a person takes phenytoin in the morning, the clinician may ask for the blood draw before the morning dose. If the schedule is different, the timing should follow the prescriber’s instructions.
Do not skip, delay, or double a dose unless the clinician specifically tells you to. Changing the dose schedule to “make the lab look better” can make the result harder to interpret and may increase seizure or toxicity risk. The lab and clinician need to know the real pattern of use.
Before the test, it helps to record:
- The exact time of the last phenytoin dose.
- The dose amount and dosage form, such as extended-release capsule, chewable tablet, liquid, IV phenytoin, or fosphenytoin.
- The usual dosing schedule.
- Any missed or late doses in the last several days.
- New prescriptions, stopped medicines, over-the-counter products, supplements, or herbal products.
- Vomiting, diarrhea, poor intake, tube feeds, or recent hospitalization.
- Any seizure activity or toxicity symptoms.
- Pregnancy status, if relevant.
Timing after a dose change matters. Phenytoin may take several days or longer to settle into a new pattern, and its nonlinear metabolism means the timing is less predictable when levels are high or doses are changing. Many clinicians recheck levels after enough time has passed for the dose change to show its effect, but urgent symptoms may require testing right away.
For people receiving phenytoin through a feeding tube, nutrition timing matters because enteral feeds can reduce absorption. The care team may separate phenytoin from tube feeds and monitor levels more closely. Liquid phenytoin also needs careful measurement because small dosing errors can matter.
A single lab result is easiest to interpret when timing is clear. A random level can still be useful in suspected toxicity, overdose, severe symptoms, or emergency care. In routine monitoring, however, comparing a random afternoon level with a previous trough can lead to confusion.
Total vs free phenytoin results
Total phenytoin is the most common test, but free phenytoin is sometimes the better test. This distinction matters because phenytoin binds strongly to albumin, a major blood protein. The bound portion acts like a reservoir. The free portion is the active portion that can cause antiseizure effects and toxicity.
In many stable adults, about 90% of phenytoin is protein-bound and about 10% is free. When albumin is low or binding is disrupted, the free percentage can rise. The total level may look normal or only mildly high, while the active level is high enough to cause toxicity.
Free phenytoin may be more useful when a person has:
- Low albumin.
- Kidney failure or significant uremia.
- Liver disease.
- Pregnancy.
- Critical illness or intensive care treatment.
- Malnutrition.
- Older age with frailty or multiple illnesses.
- A normal total phenytoin level but symptoms of toxicity.
- A confusing result after major medication changes.
- Valproic acid use, which can affect protein binding and metabolism.
Clinicians sometimes use albumin-corrected equations to estimate what the total phenytoin level might mean when albumin is low. These correction formulas can help, but they are estimates. They may be less accurate in kidney failure, critical illness, pregnancy, and complex drug interactions. When the result will affect a major decision, measuring free phenytoin directly is often more informative.
Albumin testing can therefore be important when interpreting phenytoin. A low albumin result can change how a total phenytoin number should be read. For background on this protein marker, see albumin blood test reference values.
Free phenytoin is not always available quickly in every laboratory. Some hospitals send it to a reference lab, which can delay results. In urgent cases, clinicians may make safety decisions based on symptoms, total level, albumin, kidney function, timing, and repeat testing while waiting for the free level.
Causes of high or low phenytoin levels
A high or low phenytoin result usually has an explanation, but it may take careful review. The same dose can produce different levels in different people because phenytoin absorption, protein binding, and liver metabolism vary widely.
Common causes of high phenytoin levels
A high level may occur after a dose increase, but that is not the only cause. Phenytoin can rise when the body clears it more slowly, when protein binding changes, or when another medicine interferes with metabolism.
Possible causes include:
- Taking too much phenytoin by accident.
- A recent dose increase.
- Switching formulations or brands with different absorption.
- Liver disease or reduced liver metabolism.
- Low albumin, which can raise free phenytoin.
- Kidney failure or uremia, which can change binding.
- Acute illness, poor nutrition, or critical illness.
- Interacting medicines that inhibit phenytoin metabolism.
- Reduced alcohol intake after chronic heavy use, in some situations.
- Lab timing that captured a higher post-dose level rather than a trough.
Medicines that may increase phenytoin levels or toxicity risk include some azole antifungals, amiodarone, isoniazid, certain antibiotics, some acid-reducing medicines, and other antiseizure medicines. Valproic acid deserves special attention because it can affect both protein binding and metabolism, so the total phenytoin number may not reflect the free level well. For related monitoring, see valproic acid blood test interpretation.
Common causes of low phenytoin levels
A low level may mean the dose is too low, but adherence and absorption issues are also common. Phenytoin levels can fall when doses are missed, absorption is reduced, or metabolism is increased by another drug.
Possible causes include:
- Missed doses or inconsistent timing.
- Vomiting, diarrhea, or poor absorption.
- Feeding tube nutrition reducing absorption.
- A dose that has not yet reached its full steady effect.
- Switching products or dosage forms.
- Interacting medicines that increase phenytoin metabolism.
- Chronic heavy alcohol use in some situations.
- Pregnancy-related changes in volume, binding, and clearance.
- Incorrect sample timing or documentation.
Some medicines and supplements can lower phenytoin exposure by affecting absorption or metabolism. Antacids, calcium-containing products, tube feeds, and some supplements can interfere with absorption if timing overlaps. Enzyme-inducing drugs can speed metabolism. St. John’s wort may also reduce levels or complicate medication control.
Phenytoin can also change the levels or effects of other medicines. It can reduce the effectiveness of hormonal contraceptives and interact with anticoagulants, transplant medicines, steroids, some psychiatric medicines, and other seizure medicines. A medication list review is often just as important as the lab number.
Toxicity symptoms and urgent follow-up
Phenytoin toxicity often affects the nervous system first. Mild toxicity can look like clumsiness or dizziness. More serious toxicity can cause confusion, inability to walk safely, severe sedation, abnormal heart rhythm symptoms, coma, or seizures. Because phenytoin toxicity can increase fall risk and can be dangerous at high levels, symptoms should not be ignored.
Common toxicity symptoms include:
- Nystagmus, or involuntary eye movements.
- Double vision or blurred vision.
- Dizziness or vertigo.
- Unsteady walking or loss of coordination.
- Slurred speech.
- Tremor.
- Nausea or vomiting.
- Sleepiness, slowed thinking, or confusion.
- Agitation or unusual behavior.
- Worsening seizures at very high levels or in complex overdoses.
Seek urgent medical care if symptoms are severe, rapidly worsening, or associated with fainting, chest pain, irregular heartbeat, trouble breathing, inability to stay awake, inability to walk safely, repeated vomiting, coma, or seizures. Emergency care is also needed for suspected overdose, especially if intentional ingestion is possible or other substances may have been taken.
Skin and blood-related warning signs also matter. Phenytoin can rarely cause serious skin reactions, allergic syndromes, liver injury, and blood cell problems. Seek medical attention promptly for fever with rash, mouth ulcers, facial swelling, swollen glands, easy bruising, unusual bleeding, yellowing of the skin or eyes, severe fatigue, or flu-like symptoms with a new rash.
In some people of Asian ancestry, certain genetic variants are linked with a higher risk of severe skin reactions from phenytoin. Clinicians may consider genetic testing before starting therapy in higher-risk groups, depending on ancestry and local guidance.
Phenytoin may be checked along with other toxicology or medication levels when overdose is possible. If aspirin toxicity, acetaminophen overdose, alcohol exposure, or multiple medicines could be involved, the care team may order additional tests. For example, salicylate testing is handled differently from phenytoin monitoring, as explained in salicylate blood test interpretation.
How results guide dose changes
Phenytoin dose changes should be made carefully because the drug does not behave in a straight-line way. With many medicines, increasing the dose by a small amount causes a roughly proportional rise in blood level. With phenytoin, once metabolism begins to saturate, a small dose increase can produce a large jump in level. This is one reason clinicians often adjust chronic phenytoin doses in small steps and recheck levels when needed.
A clinician may respond to a low level by asking first whether the result is trustworthy. Was the blood drawn at the intended time? Were any doses missed? Did the person recently start tube feeds, antacids, supplements, or interacting medicines? Has enough time passed since the last dose change? If seizures are controlled and there are no concerns, a slightly low level may not require a change.
A clinician may respond to a high level by looking for symptoms and causes. If the person has toxicity symptoms, the dose may be held, reduced, or changed under medical supervision. If the level is high but the person feels well, the clinician may repeat the level, check albumin or free phenytoin, review interactions, and decide whether the risk of toxicity justifies a change.
Dose decisions often include several pieces of information:
- Current total and possibly free phenytoin level.
- Seizure control.
- Toxicity symptoms.
- Albumin, liver function, kidney function, and electrolytes.
- Medication list and recent changes.
- Product formulation and dosing schedule.
- Age, pregnancy status, nutrition, and body weight.
- History of prior levels at known doses.
A kidney panel may be useful when kidney disease or uremia could alter free phenytoin interpretation. For related markers, see kidney function blood test panel results. Other antiseizure medicine levels may also be reviewed when treatment includes more than one drug, such as carbamazepine level monitoring.
People taking phenytoin should not stop it suddenly unless a clinician gives urgent instructions, because abrupt stopping can worsen seizures. If phenytoin needs to be stopped because of toxicity, rash, liver injury, pregnancy planning, or lack of seizure control, the prescriber may taper it, substitute another medicine, or provide hospital monitoring depending on risk.
A useful phenytoin result does more than label the level as low, therapeutic, or high. It helps answer whether the current dose fits the person’s seizure control and safety profile. The safest interpretation combines the lab result with symptoms, timing, albumin or free level needs, interacting medicines, and the reason the test was ordered.
References
- Phenytoin monitoring 2026 (Guidance)
- Phenytoin 2023 (Review)
- Phenytoin Toxicity 2023 (Review)
- Phenytoin: MedlinePlus Drug Information 2023 (Official Drug Information)
Disclaimer
Phenytoin results should be interpreted by a licensed clinician who knows the dose schedule, seizure history, symptoms, albumin level, kidney and liver status, and other medicines. Do not change, skip, or stop phenytoin based only on a lab result unless your prescriber gives specific instructions. Seek urgent care for severe toxicity symptoms, serious rash, suspected overdose, trouble breathing, coma, or seizures.
